Dy GK - Search Results

1

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models.

Ghazal D, Zalzala F, Fisk JC, Tati S, Karacosta LG, Morey S, Olson JR, Quataert S, Dy GK, Rittenhouse-Olson K. Ghazal D, et al. Among authors: dy gk. Oncotarget. 2022 Oct 19;13:1155-1164. doi: 10.18632/oncotarget.28282. Oncotarget. 2022. PMID: 36264086 Free PMC article.

2

Oncologist uptake of comprehensive genomic profile guided targeted therapy.

Nesline MK, DePietro P, Dy GK, Early A, Papanicolau-Sengos A, Conroy JM, Lenzo FL, Glenn ST, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Puzanov I, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Frederick P, Lele S, Gardner M, Morrison C. Nesline MK, et al. Among authors: dy gk. Oncotarget. 2019 Jul 23;10(45):4616-4629. doi: 10.18632/oncotarget.27047. eCollection 2019 Jul 23. Oncotarget. 2019. PMID: 31384390 Free PMC article.

3

Emerging therapeutic targets in non-small cell lung cancer.

Dy GK, Adjei AA. Dy GK, et al. Proc Am Thorac Soc. 2009 Apr 15;6(2):218-23. doi: 10.1513/pats.200808-099LC. Proc Am Thorac Soc. 2009. PMID: 19349491 Review.

4

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer.

Crombet Ramos T, Santos Morales O, Dy GK, León Monzón K, Lage Dávila A. Crombet Ramos T, et al. Among authors: dy gk. Front Oncol. 2021 Jun 15;11:639745. doi: 10.3389/fonc.2021.639745. eCollection 2021. Front Oncol. 2021. PMID: 34211836 Free PMC article. Review.

5

Small cell lung cancer.

Sher T, Dy GK, Adjei AA. Sher T, et al. Among authors: dy gk. Mayo Clin Proc. 2008 Mar;83(3):355-67. doi: 10.4065/83.3.355. Mayo Clin Proc. 2008. PMID: 18316005 Review.

6

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.

Zhang H, Shao H, Golubovskaya VM, Chen H, Cance W, Adjei AA, Dy GK. Zhang H, et al. Among authors: dy gk. Br J Cancer. 2016 Jul 12;115(2):203-11. doi: 10.1038/bjc.2016.190. Epub 2016 Jun 23. Br J Cancer. 2016. PMID: 27336608 Free PMC article.

7

The prognostic significance of focal adhesion kinase expression in stage I non-small-cell lung cancer.

Dy GK, Ylagan L, Pokharel S, Miller A, Brese E, Bshara W, Morrison C, Cance WG, Golubovskaya VM. Dy GK, et al. J Thorac Oncol. 2014 Sep;9(9):1278-84. doi: 10.1097/JTO.0000000000000248. J Thorac Oncol. 2014. PMID: 25122425 Free PMC article.

8

Identification of Epidermal Growth Factor Receptor Tyrosine-Kinase Mutations in Non-small Cell Lung Cancer: Testing Platform Matters.

Gandhi S, Kapoor A, Dy G. Gandhi S, et al. Cureus. 2020 Mar 18;12(3):e7316. doi: 10.7759/cureus.7316. Cureus. 2020. PMID: 32313757 Free PMC article.

9

Targeted therapies in development for non-small cell lung cancer.

Reungwetwattana T, Dy GK. Reungwetwattana T, et al. Among authors: dy gk. J Carcinog. 2013 Dec 31;12:22. doi: 10.4103/1477-3163.123972. eCollection 2013. J Carcinog. 2013. PMID: 24574860 Free PMC article. Review.

10

First-line cytotoxic chemotherapy regimen for non-small cell lung cancer in the elderly population: plus ça change.

Dy GK, Khalil M, Yau E. Dy GK, et al. Transl Lung Cancer Res. 2020 Aug;9(4):1591-1594. doi: 10.21037/tlcr-2020-15. Transl Lung Cancer Res. 2020. PMID: 32953530 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page